STING1 and neoplasm: It was found that STING agonists cGAMP could activate STING and induce the secretion of interferon (IFNs) to trigger anti-tumor immune responses, and the released IFNs in turn upregulate PD-L1 in tumor cells, which then enhance the therapeutic effect of ICB29,30.